1 Min Read
Jan 30 (Reuters) - ARAB DRUG COMPANY FOR PHARMACEUTICALS AND CHEMICAL INDUSTRIES:
* H1 NET PROFIT AFTER TAX EGP 18.4 MILLION VERSUS EGP 10.2 MILLION YEAR AGO Source: (bit.ly/2nokpjS) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.